Part 5/7:
The discussion then touches on international reviews, specifically referencing the Cast review in the UK, a well-known and comprehensive evaluation of gender-affirming medical treatments such as hormone blockers and cross-sex hormones. Critics claim that the review found the scientific evidence for these interventions to be weak, raising questions about their use.
The speaker clarifies that their previous messages may not have been entirely clear and reiterates their stance: support for transgender youth should remain a priority. They argue that, regardless of debates or apparent weaknesses in the evidence base, the overarching goal must be to support and protect vulnerable children, especially considering their significantly elevated risk of suicidal behavior.